BioSpace News Archive

Drug Development

Biopharma Update on the Novel Coronavirus: August 24

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 24, 2020.

August 24, 2020
·
2 min read
·
BioSpace Editorial Staff
Takeda Sells Japanese Consumer Health Business Unit for $2.3 Billion

This morning, Osaka, Japan-based Takeda officially announced the sale of TCHC to the investment firm.

August 24, 2020
·
2 min read
·
Alex Keown
Drug Development

Novartis’ Spartalizumab Combo Flunks Phase III Melanoma Study

Specifically, the trial of Spartalizumab did not meet the primary endpoint of investigator-assessed progression-free survival.

August 24, 2020
·
3 min read
·
Mark Terry
Policy

China Doses Some Essential Workers with COVID-19 Vaccine Ahead of Approval

There are several China-based companies that have vaccine candidates in Phase III.

August 24, 2020
·
2 min read
·
Alex Keown
Deals

Yumanity and Proteostasis Merge to Develop Neurodegenerative Compounds

They will operate after the deal as Yumanity Therapeutics, and will focus on protein misfolding and neurodegenerative diseases.

August 24, 2020
·
3 min read
·
Mark Terry
Drug Development

Rumor Mill: Trump to Approve AstraZeneca COVID-19 Before Election

According to a report, three people briefed on the plan indicated Trump wants to give AstraZeneca and the University of Oxford’s experimental COVID-19 vaccine emergency use authorization ahead of the U.S. presidential election on November 3.

August 24, 2020
·
3 min read
·
Mark Terry
Business

SERS Assay IDs Viral Mutations Early, Providing a Heads-Up for New Outbreaks and Vaccine Designers

A novel, surface enhanced Raman spectroscopy (SERS) assay that allows viral evolution and replication to be studied inside single cells.

August 24, 2020
·
4 min read
·
Gail Dutton
Policy

FDA Grants EUA for Convalescent Plasma in Hospitalized COVID-19 Patients

The U.S. FDA reversed itself Sunday following pressure from the White House and announced an Emergency Use Authorization for convalescent plasma as a treatment for patients who have contracted COVID-19.

August 24, 2020
·
3 min read
·
Alex Keown
Lone Star Bio

New Research Explains Why Cancer Cells Often Spread to the Lymph Nodes First

A study published in Nature last week explains why certain kinds of cancer cells often spread to the lymph nodes before various organs within the body.

August 24, 2020
·
2 min read
·
Krystle Vermes
Policy

Tiziana Granted a Patent on Methods and Use of Anti-IL-6/IL-6 receptor Monoclonal Antibodies as Prophylactic and Therapeutic Interventions for COVID-19 and other pulmonary diseases

Tiziana Life Sciences plc announces that the United States Patent and Trademark Office has granted a patent for methods and use of fully human monoclonal antibody that recognizes both IL-6 receptor and IL-6 receptor complex with IL-6 for prophylactic and therapeutic intervention for human diseases.

August 24, 2020
·
5 min read